| Literature DB >> 35063803 |
Sander Bekeschus1, Grit Liebelt2, Jonas Menz3, Debora Singer2, Kristian Wende2, Anke Schmidt2.
Abstract
Reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) are well-described agents in physiology and pathology. Chronic inflammation causes incessant H2O2 generation associated with disease occurrences such as diabetes, autoimmunity, and cancer. In cancer, conditioning of the tumor microenvironment, e.g., hypoxia and ROS generation, has been associated with disease outcomes and therapeutic efficacy. Many reports have investigated the roles of the action of H2O2 across many cell lines and disease models. The genes predisposing tumor cell lines to H2O2-mediated demise are less deciphered, however. To this end, we performed in-house transcriptional profiling of 35 cell lines and simultaneously investigated each cell line's H2O2 inhibitory concentration (IC25) based on metabolic activity. More than 100-fold differences were observed between the most resistant and sensitive cell lines. Correlation and gene ontology pathway analysis identified a rigid association with genes intertwined in cell cycle progression and proliferation, as such functional categories dominated the top ten significant processes. The ten most substantially correlating genes (Spearman r > 0.70 or < -0.70) were validated using qPCR, showing complete congruency with microarray analysis findings. Western blotting confirmed the correlation of cell cycle-related proteins negatively correlating with H2O2 IC25. Top genes related to ROS production or antioxidant defense were only modest in correlation (Spearman r > 0.40 or < -0.40). In conclusion, our in-house transcriptomic correlation analysis revealed a set of cell cycle-associated genes associated with a priori resistance or sensitivity to H2O2-induced cellular demise with the detailed and causative roles of individual genes remaining unclear.Entities:
Keywords: Cancer; Hydrogen peroxide; Oxidative stress; ROS; Reactive oxygen species
Mesh:
Substances:
Year: 2022 PMID: 35063803 PMCID: PMC8783094 DOI: 10.1016/j.redox.2022.102234
Source DB: PubMed Journal: Redox Biol ISSN: 2213-2317 Impact factor: 11.799
Fig. 1Study overview and ICdetermination. (a) 35 cell lines were cultured and RNA was collected from untreated cells, while in parallel, from cultured cells, the H2O2 IC25 was determined, and both data sets were correlated; (b) log-transformed H2O2 concentrations plotted against normalized metabolic activity rates of cells 24 h after exposure to H2O2, and non-linear regression analysis to identify the IC25 for each cell line; (c) waterfall plot of all cell lines sorted for IC25 and color-coded for different sensitivity ranges. Data are from three independent experiments. Grey boxes indicate the goodness of fit (R2) for each cell line. Fig. 1a created with biorender.com. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2Transcriptomic analysis. (a) hierarchical clustering of normalized gene expression across 35 cell lines confirms relationships, e.g., between the SK-MEL melanoma cell lines (right end) and the five leukemia cell lines (left) clustering together; (b) the number of genes positively or negatively correlating with IC25 values for p < 0.01 and r > 0.50 or r < −0.50, respectively; (c) display of top four classes among target compartment, molecular function, biological process, and protein class for the significantly correlating genes (538) with the values indicating the number of genes per category as per gene ontology (PANTHER) analysis; (d) normalized gene expression of the transcriptomic chip data of the top 10 target genes sorted for IC25 values and indicating the five most sensitive and resistant cell lines showing high correlation (r) values and statistical significance (yellow boxes). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Positively correlating genes. Genes, p-values, and Spearman r of genes positively correlating with resistance to H2O2-mediated cellular demise with an r > 0.50.
| gene | p-value | r | gene | p-value | r | gene | p-value | r |
|---|---|---|---|---|---|---|---|---|
| BLVRB | 1.20E-06 | 0.72 | ME1 | 3.43E-06 | 0.70 | POLD4 | 3.61E-06 | 0.69 |
| SLC35A3 | 5.96E-06 | 0.68 | KIAA1522 | 6.49E-06 | 0.68 | AREG | 7.78E-06 | 0.68 |
| CFB | 1.09E-05 | 0.67 | PTGR1 | 1.36E-05 | 0.66 | CAPZA2 | 1.49E-05 | 0.66 |
| PERP | 1.54E-05 | 0.66 | ANXA9 | 1.56E-05 | 0.66 | MOCOS | 1.70E-05 | 0.66 |
| TSPAN31 | 1.97E-05 | 0.65 | TPD52L1 | 2.55E-05 | 0.65 | TOM1L1 | 3.12E-05 | 0.64 |
| OR6K2 | 3.39E-05 | 0.64 | MTFR1 | 4.01E-05 | 0.64 | RAB26 | 5.06E-05 | 0.63 |
| FTHL17 | 5.76E-05 | 0.63 | MOS | 5.99E-05 | 0.62 | CDNF | 7.01E-05 | 0.62 |
| HSBP1L1 | 8.42E-05 | 0.62 | TC2N | 8.50E-05 | 0.61 | UGDH | 8.50E-05 | 0.61 |
| ATP8B1 | 1.03E-04 | 0.61 | ELOVL7 | 1.10E-04 | 0.61 | PRSS22 | 1.10E-04 | 0.61 |
| CCDC104 | 1.14E-04 | 0.61 | UPK3B | 1.17E-04 | 0.61 | ZFAND1 | 1.19E-04 | 0.60 |
| RNF103 | 1.22E-04 | 0.60 | LCN2 | 1.39E-04 | 0.60 | OSGIN1 | 1.44E-04 | 0.60 |
| GATA6 | 1.44E-04 | 0.60 | EXOC3L4 | 1.52E-04 | 0.60 | TMEM54 | 1.54E-04 | 0.60 |
| CEBPB | 1.68E-04 | 0.59 | CREG1 | 1.71E-04 | 0.59 | UBXN2B | 1.95E-04 | 0.59 |
| POM121L12 | 2.02E-04 | 0.59 | TSPAN1 | 2.13E-04 | 0.59 | SEL1L3 | 2.15E-04 | 0.59 |
| AQP11 | 2.15E-04 | 0.59 | EPB41L4B | 2.17E-04 | 0.59 | GRTP1 | 2.24E-04 | 0.58 |
| UGT1A6 | 2.36E-04 | 0.58 | TATDN1 | 2.36E-04 | 0.58 | FAM164C | 2.80E-04 | 0.58 |
| CCDC122 | 2.92E-04 | 0.58 | DCTN1 | 3.02E-04 | 0.58 | KRT18 | 3.02E-04 | 0.58 |
| ECI1 | 3.07E-04 | 0.57 | CTNND1 | 3.31E-04 | 0.57 | KRTAP10 | 3.39E-04 | 0.57 |
| EREG | 3.62E-04 | 0.57 | VRK2 | 3.77E-04 | 0.57 | TMC4 | 3.81E-04 | 0.57 |
| TMEM105 | 3.87E-04 | 0.57 | BCL6 | 4.09E-04 | 0.56 | FXYD3 | 4.30E-04 | 0.56 |
| DSP | 4.37E-04 | 0.56 | PKP3 | 4.44E-04 | 0.56 | CDH1 | 4.51E-04 | 0.56 |
| UBE2H | 4.55E-04 | 0.56 | AHNAK | 4.58E-04 | 0.56 | ASPH | 4.58E-04 | 0.56 |
| YIF1B | 5.04E-04 | 0.56 | PARD6B | 5.08E-04 | 0.56 | F2RL1 | 5.24E-04 | 0.56 |
| PRSS16 | 5.94E-04 | 0.55 | CLIC3 | 6.27E-04 | 0.55 | MAL2 | 6.42E-04 | 0.55 |
| BCL3 | 6.52E-04 | 0.55 | KLF5 | 6.52E-04 | 0.55 | PCDH1 | 6.52E-04 | 0.55 |
| FAM118A | 6.88E-04 | 0.55 | KBTBD13 | 7.04E-04 | 0.55 | FA2H | 7.14E-04 | 0.54 |
| CDS1 | 7.14E-04 | 0.54 | LGALS3 | 7.20E-04 | 0.54 | MALL | 7.31E-04 | 0.54 |
| TMC5 | 7.48E-04 | 0.54 | ASB16 | 7.48E-04 | 0.54 | SYT7 | 7.59E-04 | 0.54 |
| MTUS1 | 7.65E-04 | 0.54 | CHMP4C | 7.71E-04 | 0.54 | ITGB4 | 7.82E-04 | 0.54 |
| CLDN23 | 7.88E-04 | 0.54 | IGF1R | 9.69E-04 | 0.54 | SCNN1A | 8.43E-04 | 0.54 |
| PLLP | 8.56E-04 | 0.54 | MARVELD2 | 8.56E-04 | 0.54 | NHLRC1 | 8.82E-04 | 0.54 |
| RAB17 | 8.82E-04 | 0.54 | FANK1 | 8.82E-04 | 0.54 | TTC39A | 9.01E-04 | 0.54 |
| BHLHE41 | 9.01E-04 | 0.54 | S100A14 | 9.01E-04 | 0.54 | EPCAM | 9.01E-04 | 0.54 |
| CXCL16 | 9.28E-04 | 0.54 | KIAA1244 | 9.35E-04 | 0.53 | UGT1A8 | 9.63E-04 | 0.53 |
| PLA2G10 | 9.63E-04 | 0.53 | TMEM125 | 1.04E-03 | 0.53 | GOLGA5 | 1.11E-03 | 0.53 |
| IL28A | 1.13E-03 | 0.53 | MYO5B | 1.15E-03 | 0.53 | CAV2 | 1.15E-03 | 0.53 |
| BOD1 | 1.16E-03 | 0.53 | HM13 | 1.19E-03 | 0.53 | PDGFB | 1.42E-03 | 0.53 |
| FOXA1 | 1.21E-03 | 0.52 | MYEOV | 1.21E-03 | 0.52 | NXPH4 | 1.27E-03 | 0.52 |
| SH3D19 | 1.31E-03 | 0.52 | PPFIA1 | 1.32E-03 | 0.52 | LHX1 | 1.38E-03 | 0.52 |
| PHGR1 | 1.40E-03 | 0.52 | MBNL2 | 1.41E-03 | 0.52 | EPB41L5 | 1.46E-03 | 0.52 |
| FAM179B | 1.47E-03 | 0.52 | FAM83H | 1.47E-03 | 0.52 | CSNK1A1L | 1.49E-03 | 0.52 |
| MYNN | 1.56E-03 | 0.51 | IQCK | 1.60E-03 | 0.51 | VTN | 1.60E-03 | 0.51 |
| TMEM61 | 1.62E-03 | 0.51 | SERPINA3 | 1.62E-03 | 0.51 | EPS8L2 | 1.63E-03 | 0.51 |
| CD8A | 1.63E-03 | 0.51 | BTBD16 | 1.63E-03 | 0.51 | CALCOCO2 | 1.65E-03 | 0.51 |
| BUD31 | 1.68E-03 | 0.51 | MUC1 | 1.69E-03 | 0.51 | MTA3 | 1.69E-03 | 0.51 |
| ADPRHL1 | 1.70E-03 | 0.51 | KLF4 | 1.71E-03 | 0.51 | ANKRD2 | 1.71E-03 | 0.51 |
| RNLS | 1.72E-03 | 0.51 | YES1 | 1.76E-03 | 0.51 | METRNL | 2.10E-03 | 0.51 |
| ZNF572 | 1.79E-03 | 0.51 | KRTAP6-2 | 1.81E-03 | 0.51 | KRT8 | 1.82E-03 | 0.51 |
| GDF15 | 1.83E-03 | 0.51 | PROM2 | 1.83E-03 | 0.51 | MET | 1.87E-03 | 0.51 |
| DNAJB9 | 1.88E-03 | 0.51 | MECOM | 1.89E-03 | 0.51 | GLCE | 1.91E-03 | 0.51 |
| NTF4 | 1.92E-03 | 0.51 | KRT19 | 2.00E-03 | 0.50 | RHOD | 2.01E-03 | 0.50 |
| A4GALT | 2.01E-03 | 0.50 | GJB2 | 2.03E-03 | 0.50 | RBCK1 | 2.03E-03 | 0.50 |
| PTK6 | 2.39E-03 | 0.50 | C5orf32 | 2.04E-03 | 0.50 | SOCS6 | 2.10E-03 | 0.50 |
| NFIL3 | 2.12E-03 | 0.50 | PLEKHH2 | 2.15E-03 | 0.50 | GABRE | 2.21E-03 | 0.50 |
| TSPAN15 | 2.21E-03 | 0.50 | LONP2 | 2.31E-03 | 0.50 | EFNA1 | 2.31E-03 | 0.50 |
| DEGS2 | 2.31E-03 | 0.50 | SYBU | 2.36E-03 | 0.50 | INADL | 2.36E-03 | 0.50 |
| CDC91 | 2.38E-03 | 0.50 | DYNC2LI1 | 2.41E-03 | 0.50 | NRIP1 | 2.44E-03 | 0.50 |
| ADAM9 | 2.46E-03 | 0.50 | / | / | / | / | / | / |
Negatively correlating genes. Genes, p-values, and Spearman r of genes negatively correlating with resistance to H2O2-mediated cellular demise with an r < −0.50.
| gene | p-value | r | gene | p-value | r | gene | p-value | r |
|---|---|---|---|---|---|---|---|---|
| TUBB | 3.82E-07 | −0.74 | STMN1 | 5.50E-07 | −0.73 | SIRPG | 5.93E-07 | −0.73 |
| DTL | 6.02E-07 | −0.73 | SACS | 1.77E-06 | −0.71 | NCAPG | 2.83E-06 | −0.70 |
| MCM10 | 3.06E-06 | −0.70 | CDC25A | 3.26E-06 | −0.70 | CPXM1 | 3.76E-06 | −0.69 |
| H2BFM | 3.95E-06 | −0.69 | NRGN | 1.20E-05 | −0.67 | GTSE1 | 1.38E-05 | −0.66 |
| NEUROG2 | 1.52E-05 | −0.66 | LIMD2 | 1.68E-05 | −0.66 | CCDC28B | 1.74E-05 | −0.66 |
| NASP | 1.92E-05 | −0.66 | PSMC2 | 1.99E-05 | −0.65 | MCM2 | 2.37E-05 | −0.65 |
| TACC3 | 2.37E-05 | −0.65 | BLM | 2.75E-05 | −0.65 | CDCA8 | 2.81E-05 | −0.65 |
| MLF1IP | 2.81E-05 | −0.65 | RNASE6 | 2.81E-05 | −0.65 | GPR63 | 2.87E-05 | −0.65 |
| MKI67 | 3.09E-05 | −0.64 | RFTN1 | 3.29E-05 | −0.64 | ZNF124 | 3.96E-05 | −0.64 |
| XRCC2 | 4.26E-05 | −0.63 | CCNA2 | 4.35E-05 | −0.63 | PHF19 | 4.39E-05 | −0.63 |
| HIC1 | 5.43E-05 | −0.63 | FBXO5 | 5.53E-05 | −0.63 | OSM | 5.59E-05 | −0.63 |
| HNRNPU | 6.23E-05 | −0.62 | TAGAP | 6.74E-05 | −0.62 | ORC6 | 6.94E-05 | −0.62 |
| RNASE2 | 7.22E-05 | −0.62 | UBE2T | 7.29E-05 | −0.62 | MCART6 | 7.95E-05 | −0.62 |
| BTK | 8.10E-05 | −0.62 | ZNF692 | 8.26E-05 | −0.62 | MCM5 | 8.58E-05 | −0.61 |
| NCAPD2 | 8.91E-05 | −0.61 | CXXC1 | 8.91E-05 | −0.61 | EIF4E2 | 9.00E-05 | −0.61 |
| CORO1A | 9.98E-05 | −0.61 | FANCA | 9.98E-05 | −0.61 | KIAA0586 | 9.98E-05 | −0.61 |
| UHRF1 | 1.08E-04 | −0.61 | PTPN22 | 1.09E-04 | −0.61 | MIS18A | 1.12E-04 | −0.61 |
| ELAVL1 | 1.14E-04 | −0.61 | HELLS | 1.15E-04 | −0.61 | ESPL1 | 1.17E-04 | −0.61 |
| ITPRIPL1 | 1.24E-04 | −0.60 | SAP30 | 1.25E-04 | −0.60 | NUP62 | 1.28E-04 | −0.60 |
| CCDC77 | 1.35E-04 | −0.60 | EME1 | 1.37E-04 | −0.60 | PLEKHO1 | 1.39E-04 | −0.60 |
| FMNL3 | 1.39E-04 | −0.60 | DIAPH3 | 1.42E-04 | −0.60 | VRK1 | 1.52E-04 | −0.60 |
| DBF4B | 1.52E-04 | −0.60 | KCNA6 | 1.62E-04 | −0.60 | DNA2 | 1.64E-04 | −0.59 |
| PTGIR | 1.69E-04 | −0.59 | ZNF100 | 1.73E-04 | −0.59 | ORC1 | 1.74E-04 | −0.59 |
| TYMS | 1.82E-04 | −0.59 | SRRT | 1.88E-04 | −0.59 | KIF11 | 1.88E-04 | −0.59 |
| FHOD1 | 1.92E-04 | −0.59 | IL12RB1 | 1.93E-04 | −0.59 | HIVEP3 | 1.95E-04 | −0.59 |
| KIF2C | 1.99E-04 | −0.59 | TNFAIP8L2 | 2.02E-04 | −0.59 | KIF14 | 2.07E-04 | −0.59 |
| CLSPN | 2.07E-04 | −0.59 | CEP85 | 2.07E-04 | −0.59 | RAD54L | 2.09E-04 | −0.59 |
| JAM2 | 2.15E-04 | −0.59 | RUFY2 | 2.19E-04 | −0.59 | C1orf187 | 2.20E-04 | −0.59 |
| RAD54L2 | 2.22E-04 | −0.59 | FANCD2 | 2.24E-04 | −0.58 | KIF15 | 2.24E-04 | −0.58 |
| PDXP | 2.24E-04 | −0.58 | E2F1 | 2.26E-04 | −0.58 | GTPBP3 | 2.36E-04 | −0.58 |
| MAP3K4 | 2.40E-04 | −0.58 | DNAJB5 | 2.42E-04 | −0.58 | CASC5 | 2.49E-04 | −0.58 |
| ZADH2 | 2.51E-04 | −0.58 | SETMAR | 2.57E-04 | −0.58 | SLA | 2.71E-04 | −0.58 |
| WASF1 | 2.71E-04 | −0.58 | SLA | 2.71E-04 | −0.58 | BIRC5 | 2.71E-04 | −0.58 |
| TNFRSF8 | 2.78E-04 | −0.58 | WDR76 | 2.94E-04 | −0.58 | CCNF | 2.97E-04 | −0.58 |
| TSPYL4 | 3.02E-04 | −0.58 | TDP1 | 3.05E-04 | −0.57 | CD244 | 3.05E-04 | −0.57 |
| MEX3B | 3.07E-04 | −0.57 | EVI2A | 3.10E-04 | −0.57 | CENPE | 3.12E-04 | −0.57 |
| HNRNPA3 | 3.15E-04 | −0.57 | EBLN2 | 3.15E-04 | −0.57 | PHRF1 | 3.20E-04 | −0.57 |
| BUB1B | 3.34E-04 | −0.57 | NCKAP1L | 3.36E-04 | −0.57 | CENPJ | 3.54E-04 | −0.57 |
| NKG7 | 3.56E-04 | −0.57 | FADS2 | 4.55E-04 | −0.57 | MYLK2 | 3.74E-04 | −0.57 |
| MCM3 | 3.74E-04 | −0.57 | WTAP | 3.74E-04 | −0.57 | POLQ | 3.81E-04 | −0.57 |
| PTPRC | 3.81E-04 | −0.57 | FDXACB1 | 3.84E-04 | −0.57 | E2F2 | 3.90E-04 | −0.57 |
| MCM6 | 4.30E-04 | −0.56 | PURG | 4.33E-04 | −0.56 | TROAP | 4.33E-04 | −0.56 |
| PIF1 | 4.40E-04 | −0.56 | RFC3 | 4.58E-04 | −0.56 | SMAP2 | 4.62E-04 | −0.56 |
| CHAF1A | 4.62E-04 | −0.56 | SMAP2 | 4.62E-04 | −0.56 | FCHSD2 | 4.66E-04 | −0.56 |
| SIRPB1 | 4.73E-04 | −0.56 | ABCD2 | 4.77E-04 | −0.56 | DDX39A | 4.77E-04 | −0.56 |
| OPRL1 | 4.84E-04 | −0.56 | KIAA1661 | 4.88E-04 | −0.56 | ST8SIA5 | 5.00E-04 | −0.56 |
| LMNB1 | 5.04E-04 | −0.56 | VPRBP | 5.04E-04 | −0.56 | MASTL | 5.08E-04 | −0.56 |
| DNMT1 | 5.24E-04 | −0.56 | RBM15 | 5.28E-04 | −0.56 | ZNF878 | 5.33E-04 | −0.56 |
| GMNN | 5.37E-04 | −0.56 | MAPRE2 | 5.37E-04 | −0.56 | ILF3 | 5.45E-04 | −0.55 |
| SRSF1 | 5.54E-04 | −0.55 | PPP2R3B | 5.54E-04 | −0.55 | AP1M1 | 5.63E-04 | −0.55 |
| MPO | 5.63E-04 | −0.55 | RRM1 | 5.67E-04 | −0.55 | SPC25 | 5.67E-04 | −0.55 |
| SPC25 | 5.67E-04 | −0.55 | FERMT3 | 5.71E-04 | −0.55 | HVCN1 | 5.80E-04 | −0.55 |
| WDR62 | 5.80E-04 | −0.55 | POLE2 | 5.85E-04 | −0.55 | CEP44 | 5.85E-04 | −0.55 |
| ARID3B | 5.90E-04 | −0.55 | POLA1 | 5.90E-04 | −0.55 | SLC9B2 | 5.94E-04 | −0.55 |
| GTF3C3 | 5.94E-04 | −0.55 | POC1A | 5.99E-04 | −0.55 | SEZ6 | 6.03E-04 | −0.55 |
| MXD3 | 6.22E-04 | −0.55 | LIG1 | 7.61E-04 | −0.55 | LIG1 | 7.61E-04 | −0.55 |
| ZNF519 | 6.32E-04 | −0.55 | ADRBK2 | 6.32E-04 | −0.55 | ZNF589 | 6.42E-04 | −0.55 |
| CENPO | 6.57E-04 | −0.55 | BCOR | 6.62E-04 | −0.55 | ZCCHC18 | 6.67E-04 | −0.55 |
| HNRNPD | 6.82E-04 | −0.55 | SUV39H1 | 6.82E-04 | −0.55 | GUCY1A3 | 6.98E-04 | −0.55 |
| TPM3 | 7.04E-04 | −0.55 | PASK | 7.14E-04 | −0.54 | IQSEC3 | 7.14E-04 | −0.54 |
| ANKRD36B | 7.14E-04 | −0.54 | RASSF5 | 7.25E-04 | −0.54 | GAMT | 7.31E-04 | −0.54 |
| GPR183 | 8.88E-04 | −0.54 | PDSS1 | 7.36E-04 | −0.54 | SRSF2 | 7.48E-04 | −0.54 |
| LAIR2 | 7.48E-04 | −0.54 | EVI2B | 7.48E-04 | −0.54 | ARHGAP19 | 7.53E-04 | −0.54 |
| CEBPE | 7.59E-04 | −0.54 | ACAT2 | 7.65E-04 | −0.54 | ACAT2 | 7.65E-04 | −0.54 |
| MYBL2 | 9.24E-04 | −0.54 | RPL27A | 7.76E-04 | −0.54 | SFMBT2 | 7.94E-04 | −0.54 |
| HNRNPA2B1 | 8.00E-04 | −0.54 | IL10RA | 8.06E-04 | −0.54 | CFP | 8.06E-04 | −0.54 |
| SLAMF6 | 8.18E-04 | −0.54 | P2RY10 | 8.43E-04 | −0.54 | GPR174 | 8.43E-04 | −0.54 |
| CSRNP3 | 8.43E-04 | −0.54 | KIF26B | 8.56E-04 | −0.54 | GINS3 | 8.62E-04 | −0.54 |
| ARHGAP11A | 8.69E-04 | −0.54 | SGOL2 | 8.75E-04 | −0.54 | ZNF407 | 8.95E-04 | −0.54 |
| ATP6V1G2 | 9.01E-04 | −0.54 | APOBEC3G | 9.01E-04 | −0.54 | C12orf24 | 9.35E-04 | −0.53 |
| PVRIG | 9.35E-04 | −0.53 | ASF1B | 9.42E-04 | −0.53 | DCAF15 | 9.63E-04 | −0.53 |
| NARF | 9.63E-04 | −0.53 | SAMSN1 | 9.70E-04 | −0.53 | AGPAT5 | 9.92E-04 | −0.53 |
| KIFC1 | 9.92E-04 | −0.53 | TRAF3IP3 | 9.99E-04 | −0.53 | FANCB | 1.01E-03 | −0.53 |
| SPC24 | 1.01E-03 | −0.53 | GIMAP8 | 1.03E-03 | −0.53 | SLC4A8 | 1.04E-03 | −0.53 |
| CMTM3 | 1.05E-03 | −0.53 | RRM2 | 1.06E-03 | −0.53 | VKORC1 | 1.06E-03 | −0.53 |
| CCDC136 | 1.07E-03 | −0.53 | ZWINT | 1.09E-03 | −0.53 | MTR | 1.09E-03 | −0.53 |
| SOX12 | 1.11E-03 | −0.53 | SOX12 | 1.11E-03 | −0.53 | TXLNB | 1.11E-03 | −0.53 |
| ZNF273 | 1.11E-03 | −0.53 | GCFC1 | 1.11E-03 | −0.53 | ZKSCAN4 | 1.11E-03 | −0.53 |
| DACT3 | 1.12E-03 | −0.53 | LILRB4 | 1.12E-03 | −0.53 | AGER | 1.13E-03 | −0.53 |
| FRYL | 1.13E-03 | −0.53 | SLC25A19 | 1.15E-03 | −0.53 | GNGT2 | 1.15E-03 | −0.53 |
| TSHZ1 | 1.15E-03 | −0.53 | CBX2 | 1.17E-03 | −0.53 | EMILIN1 | 1.18E-03 | −0.53 |
| TLE4 | 1.18E-03 | −0.53 | ARHGAP9 | 1.20E-03 | −0.53 | MYBPC2 | 1.21E-03 | −0.52 |
| CCNC | 1.21E-03 | −0.52 | RGS1 | 1.22E-03 | −0.52 | DOK3 | 1.22E-03 | −0.52 |
| PLK4 | 1.25E-03 | −0.52 | RBM14 | 1.29E-03 | −0.52 | HNRNPL | 1.29E-03 | −0.52 |
| RGS9 | 1.29E-03 | −0.52 | PRKCB | 1.30E-03 | −0.52 | MS4A7 | 1.30E-03 | −0.52 |
| CTSC | 1.31E-03 | −0.52 | ARHGAP33 | 1.31E-03 | −0.52 | CEP135 | 1.35E-03 | −0.52 |
| CCL3 | 1.38E-03 | −0.52 | CBX5 | 1.39E-03 | −0.52 | PMS1 | 1.44E-03 | −0.52 |
| WRAP53 | 1.47E-03 | −0.52 | BMP2K | 1.48E-03 | −0.52 | VASH2 | 1.48E-03 | −0.52 |
| FANCG | 1.49E-03 | −0.52 | SAFB | 1.50E-03 | −0.52 | LILRB1 | 1.52E-03 | −0.52 |
| ANKRD20A1 | 1.52E-03 | −0.52 | ORAI2 | 1.54E-03 | −0.52 | ANKRD32 | 1.54E-03 | −0.52 |
| WDR82 | 1.55E-03 | −0.51 | CD37 | 1.55E-03 | −0.51 | ACAP1 | 1.57E-03 | −0.51 |
| PLK1 | 1.57E-03 | −0.51 | FBXO43 | 1.61E-03 | −0.51 | DOK2 | 1.61E-03 | −0.51 |
| SLC6A13 | 1.62E-03 | −0.51 | SF3B1 | 1.64E-03 | −0.51 | FUS | 1.64E-03 | −0.51 |
| CYTH1 | 1.64E-03 | −0.51 | HMGB2 | 1.64E-03 | −0.51 | KRI1 | 1.65E-03 | −0.51 |
| FANCM | 1.65E-03 | −0.51 | NLRP13 | 1.65E-03 | −0.51 | METTL3 | 1.66E-03 | −0.51 |
| ADORA2A | 1.68E-03 | −0.51 | DOT1L | 1.69E-03 | −0.51 | BUB3 | 1.69E-03 | −0.51 |
| SRSF3 | 1.69E-03 | −0.51 | CAPN6 | 1.70E-03 | −0.51 | UNC13C | 1.71E-03 | −0.51 |
| PARVG | 1.72E-03 | −0.51 | ESPNL | 1.73E-03 | −0.51 | LUC7L3 | 1.75E-03 | −0.51 |
| PKHD1L1 | 1.75E-03 | −0.51 | PNN | 1.75E-03 | −0.51 | SMARCC1 | 1.75E-03 | −0.51 |
| TRAIP | 1.77E-03 | −0.51 | BARD1 | 1.77E-03 | −0.51 | RAG2 | 1.78E-03 | −0.51 |
| LSM2 | 1.79E-03 | −0.51 | GNAI2 | 1.79E-03 | −0.51 | CCDC75 | 1.81E-03 | −0.51 |
| SRSF11 | 1.81E-03 | −0.51 | CNTROB | 1.81E-03 | −0.51 | HJURP | 1.83E-03 | −0.51 |
| EXO1 | 1.83E-03 | −0.51 | MND1 | 1.84E-03 | −0.51 | GEMIN4 | 1.84E-03 | −0.51 |
| TERT | 1.84E-03 | −0.51 | PTPN7 | 1.84E-03 | −0.51 | CXCR4 | 1.87E-03 | −0.51 |
| ACIN1 | 1.93E-03 | −0.51 | LEPROT | 1.93E-03 | −0.51 | DNASE1L3 | 1.96E-03 | −0.51 |
| ING3 | 1.97E-03 | −0.51 | TTN | 1.99E-03 | −0.50 | PRPS1 | 1.99E-03 | −0.50 |
| MYO1G | 2.00E-03 | −0.50 | FRMD4A | 2.03E-03 | −0.50 | INCENP | 2.03E-03 | −0.50 |
| LCORL | 2.03E-03 | −0.50 | ZC4H2 | 2.04E-03 | −0.50 | WDR6 | 2.05E-03 | −0.50 |
| GPSM3 | 2.07E-03 | −0.50 | XAB2 | 2.08E-03 | −0.50 | SASH3 | 2.10E-03 | −0.50 |
| ANXA6 | 2.11E-03 | −0.50 | SAP25 | 2.11E-03 | −0.50 | UPB1 | 2.12E-03 | −0.50 |
| LIX1L | 2.17E-03 | −0.50 | CDC42 | 2.17E-03 | −0.50 | TNFAIP8L1 | 2.18E-03 | −0.50 |
| NRXN2 | 2.18E-03 | −0.50 | CSTF3 | 2.20E-03 | −0.50 | IL16 | 2.21E-03 | −0.50 |
| CKS2 | 2.21E-03 | −0.50 | RBM10 | 2.21E-03 | −0.50 | PSTPIP1 | 2.22E-03 | −0.50 |
| E2F7 | 2.22E-03 | −0.50 | MICAL1 | 2.22E-03 | −0.50 | KIAA0748 | 2.22E-03 | −0.50 |
| KBTBD8 | 2.24E-03 | −0.50 | FGFR1 | 2.25E-03 | −0.50 | KIF22 | 2.25E-03 | −0.50 |
| PARP1 | 2.25E-03 | −0.50 | MCM7 | 2.28E-03 | −0.50 | SPAG6 | 2.28E-03 | −0.50 |
| SEPT03 | 2.28E-03 | −0.50 | UNC79 | 2.28E-03 | −0.50 | MYO18B | 2.31E-03 | −0.50 |
| ZKSCAN3 | 2.35E-03 | −0.50 | DHX30 | 2.35E-03 | −0.50 | EGFEM1P | 2.38E-03 | −0.50 |
| GCDH | 2.38E-03 | −0.50 | NLRP12 | 2.38E-03 | −0.50 | LAX1 | 2.39E-03 | −0.50 |
| CD53 | 2.39E-03 | −0.50 | DNAJC9 | 2.39E-03 | −0.50 | KSR1 | 2.41E-03 | −0.50 |
| CD69 | 2.41E-03 | −0.50 | HGF | 2.44E-03 | −0.50 | CACNB2 | 2.44E-03 | −0.50 |
| AGAP2 | 2.47E-03 | −0.50 | NKTR | 2.49E-03 | −0.50 | / | / | / |
Pathway enrichment. Functional category, enrichment false discovery rate (FDR), and the number of pathway-related genes of all significantly correlating genes with an r > 0.50 or r < −0.50.
| Functional category | Enrichment FDR | Number of genes (r > 0.50) |
|---|---|---|
| Mitotic cell cycle process | 1.2E-22 | 83 |
| Cell cycle | 2.3E-22 | 124 |
| Mitotic cell cycle | 5.4E-22 | 88 |
| Cell cycle process | 1.5E-20 | 102 |
| DNA replication | 2.5E-15 | 38 |
| Chromosome organization | 1.9E-12 | 79 |
| DNA-dependent DNA replication | 2.8E-12 | 26 |
| Mitotic nuclear division | 2.8E-12 | 35 |
| Nuclear division | 3.2E-12 | 43 |
| Organelle organization | 1.2E-11 | 169 |
Fig. 3Top 10 target validation. (a) validation of target genes using qPCR in eight selected cell lines (four sensitives, four resistant) from two experiments shown as box plots and fully confirming findings by transcriptomic analysis (grey boxes, significant and high correlation between expression and H2O2 IC25); (b) graphical display of six of the ten target genes being directly involved in cell cycle progression; (c) representative Western blot images from capillary-based gel electrophoresis (WES) for six cell lines and indicating two representative targets; (d) quantitative protein expression from three experiments after normalization against GAPDH and plotted against the predetermined H2O2 IC25, grey box indicating Spearman correlation. Fig. 3b created with biorender.com.
Fig. 4Transcription factor gene expression. (a) heatmap of relative transcription factor expression normalized to the mean expression of each gene across all 35 cell lines sorted for positive and negative correlation (r) against the H2O2 IC25 of each cell line; (b) transcription factors with Spearman r > 0.5 (left) and <-0.5 (right) and their relative expression graphed for cell lines 1–18 with low to medium H2O2 IC25 values and cell lines 19–35 with medium to high H2O2 IC25 values. Statistical analysis was done using Mann-Whitney test with p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***); (c) principal component (PC) analysis of the relative expression of the transcription factors of (a) across all cell lines identifies PC2 to segregate between H2O2-sensitive (top, red boxes) and resistant (bottom, green boxes) cell lines. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Correlation of ROS-related proteins. Given are genes and protein names of ROS-related and antioxidant proteins positively (left) and negatively (right) correlating to H2O2 IC25 values. Genes with Spearman r correlations of >0.40 and <-0.40 are marked in grey.
| Gene | Protein | r (+) | Gene | Protein | r (−) |
|---|---|---|---|---|---|
| GPX2 | glutathione peroxidase 2 | 0.44 | NOS2 | nitric oxide synthase, inducible | −0.45 |
| NOXA1 | NADPH oxidase activator 1, NOX activator 1 | 0.42 | GPX7 | glutathione peroxidase 7 | −0.41 |
| GSTO2 | glutathione S-transferase omega 2 | 0.41 | GSTCD | glutathione S-transferase A7 | −0.40 |
| NOXO1 | NADPH oxidase organizer 1 | 0.26 | GSTA7P | glutathione S-transferase CD | −0.39 |
| TXNDC5 | thioredoxin domain-containing protein 5 | 0.26 | GSTM5 | glutathione S-transferase Mu 5 | −0.35 |
| GSTZ1 | glutathione S-transferase zeta 1 | 0.26 | GSTM2 | glutathione S-transferase Mu 2 | −0.33 |
| ENOX2 | ecto-NOX disulfide-thiol exchanger 2 | 0.21 | GPX6 | glutathione peroxidase 6 | −0.33 |
| GSTT1 | glutathione S-transferase T1 | 0.21 | TXN2 | thioredoxin 2 | −0.30 |
| TXN | thioredoxin | 0.20 | GSTM2P1 | glutathione S-transferase Mu2P1 | −0.29 |
| SOD2 | superoxide dismutase 2 | 0.18 | GSTTP1 | glutathione S-transferase TP1 | −0.27 |
| GSTK1 | glutathione S-transferase kappa 1 | 0.17 | TXNDC3 | thioredoxin domain-containing protein 3 | −0.26 |
| GSTA5 | glutathione S-transferase A7P | 0.17 | NOX1 | NADPH oxidase 1 | −0.25 |
| PRDX5 | peroxiredoxine 5 | 0.17 | GSTTP2 | glutathione S-transferase TP2 | −0.24 |
| TXNIP | thioredoxin interacting protein | 0.16 | NOX3 | NADPH oxidase 3 | −0.24 |
| GPX8 | glutathione peroxidase 8 | 0.16 | NOX4 | NADPH oxidase 4 | −0.23 |
| GSTT2 | glutathione S-transferase T2 | 0.15 | NOS3 | nitric oxide synthase, endothelial | −0.22 |
| PRDX4 | peroxiredoxine 4 | 0.15 | TXNDC16 | thioredoxin domain-containing protein 16 | −0.20 |
| TXNL4B | thioredoxin-like protein 4B | 0.14 | TXNL4A | thioredoxin-like protein 4A | −0.20 |
| GPX4 | glutathione peroxidase 4 | 0.14 | NOS1 | nitric oxide synthase | −0.18 |
| TXNDC9 | thioredoxin domain-containing protein9 | 0.14 | TXNDC8 | thioredoxin domain-containing protein 8 | −0.17 |
| TXNDC12 | thioredoxin domain-containing protein 12 | 0.12 | PRDX2 | peroxiredoxine 2 | −0.16 |
| GSTP1 | glutathione S-transferase P1 | 0.12 | SOD1 | superoxide dismutase 1 | −0.14 |
| DUOX2 | Dual oxidase 2 | 0.12 | TXNL1 | thioredoxin-like protein 1 | −0.14 |
| GSTT2B | glutathione S-transferase T2B | 0.12 | ENOX1 | ecto-NOX disulfide-thiol exchanger 1 | −0.13 |
| PRDX6 | peroxiredoxine 6 | 0.11 | NOX5 | NADPH oxidase 5 | −0.10 |
| DUOX1 | Dual oxidase 1 | 0.10 | CAT | catalase | −0.09 |
| GPX5 | glutathione peroxidase 5 | 0.10 | GSTA3 | glutathione S-transferase A3 | −0.08 |
| PRDX1 | peroxiredoxine 1 | 0.09 | TXNDC2 | thioredoxin domain-containing protein 2 | −0.07 |
| GSR | glutathion reductase | 0.08 | TXNDC17 | thioredoxin domain-containing protein 17 | −0.07 |
| PRDX3 | peroxiredoxine 3 | 0.05 | GSTO1 | glutathione S-transferase omega 1 | −0.05 |
| GSS | glutathion synthetase | 0.05 | GSTA2 | glutathione S-transferase A2 | −0.02 |
| TXNDC11 | thioredoxin domain-containing protein 11 | 0.04 | TXNDC15 | thioredoxin domain-containing protein 15 | −0.01 |
| GSTM3 | glutathione S-transferase Mu 3 | 0.03 | GSTM1 | glutathione S-transferase Mu 1 | −0.01 |
| GSTA4 | glutathione S-transferase A4 | 0.02 | |||
| GSTM4 | glutathione S-transferase Mu 4 | 0.02 | |||
| SOD3 | super oxide dismutase 3 | 0.01 | |||
| GPX3 | glutathione peroxidase 3 | 0.01 | |||
| GPX1 | glutathione peroxidase 1 | 0.00 |